Leptin enhances the aromatase expression in the MCF-7 (ER-positive) cell line and can activate the ER in the same cell line, implying that leptin can induce breast cancer progression through the previously outlined effects by estrogens [165,166]. This evidence concerns the gene LEP and breast carcinoma.